Feb 1 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 578 mln 504 mln 982 mln
(+14.6 pct) (-1.3 pct) (+29.6 pct)
Operating loss 65 mln loss 66 mln loss 25 mln
Recurring loss 62 mln loss 62 mln loss 24 mln
Net loss 76 mln loss 68 mln loss 39 mln
EPS loss 9.03 yen loss 9.22 yen loss 4.68 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T